To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene AP2A1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
435 supporting clones for gene AP2A1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
NM_014203.2   .a 1 to 3499 1 to 3499 exact RefSeq,   3499/3499
(100 %)
0 diff
(100 %id)
AK094317 cerebellum .a 1565 to 3497 1 to 1933   tiling clone, available from FLJ,   1933/1933
(100 %)
1 diff
(100.0 %id)
BQ638921 eye, retina .a 1774 to 2405 1 to 632       632/632
(100 %)
0 diff
(100 %id)
DA068834 cerebellum .a 1923 to 2494 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA063245 cerebellum .a 1926 to 2499 2 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
BI755498 brain .a 2011 to 2688 1 to 680       680/813
(83 %)
16 diff
(98.1 %id)
TI_57218808   .a 2011 to 2688 106 to 785       680/918
(74 %)
20 diff
(97.9 %id)
DA058254 cerebellum .a 2046 to 2613 2 to 569   tiling clone, capped   568/568
(100 %)
0 diff
(100 %id)
BF944013 nervous_normal .a 2303 to 2722 9 to 427       419/427
(98 %)
6 diff
(98.6 %id)
NM_130787.2   .b 1 to 3433 1 to 3433 exact RefSeq,   3433/3433
(100 %)
0 diff
(100 %id)
DB036036 testis .b 47 to 601 2 to 558   tiling clone, capped   557/557
(100 %)
4 diff
(99.3 %id)
BM561882 leukocyte .b 66 to 782 72 to 799       728/1249
(58 %)
19 diff
(98.5 %id)
TI_57221554   .b 68 to 917 56 to 919       861/972
(88 %)
26 diff
(97.4 %id)
CN255926 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 73 to 655 1 to 587       587/587
(100 %)
4 diff
(99.4 %id)
BG763076 melanotic melanoma, high MDR (cell line), skin .b 74 to 716 1 to 644       644/645
(99 %)
5 diff
(99.3 %id)
BI757247 brain .b 77 to 917 1 to 856       853/909
(93 %)
21 diff
(97.7 %id)
BU931133 ovary, teratocarcinoma, cell line .b 80 to 901 1 to 832       832/893
(93 %)
10 diff
(98.9 %id)
CN255932 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 82 to 537 1 to 456       456/456
(100 %)
2 diff
(99.6 %id)
BU528473 epidermoid carcinoma, cell line, lung .b 82 to 922 13 to 856       844/894
(94 %)
21 diff
(97.7 %id)
BU527855 epidermoid carcinoma, cell line, lung .b 83 to 931 1 to 849       849/849
(100 %)
6 diff
(99.3 %id)
DB146868 thymus .b 83 to 650 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
BQ058597 lymph, lymphoma, cell line .b 86 to 915 41 to 871       831/1057
(78 %)
27 diff
(97.5 %id)
BQ064203 lymph, lymphoma, cell line .b 86 to 815 7 to 737       731/940
(77 %)
12 diff
(98.8 %id)
DA966950 stomach .b 86 to 660 2 to 576   capped   575/575
(100 %)
2 diff
(99.7 %id)
DB252019 uterus .b 86 to 605 2 to 522   capped   521/521
(100 %)
2 diff
(99.7 %id)
BU189718 eye, retinoblastoma .b 87 to 696 5 to 614       610/971
(62 %)
22 diff
(97.8 %id)
BQ943812 large cell carcinoma, lung .b 89 to 1031 34 to 980       947/995
(95 %)
45 diff
(95.5 %id)
DA391780 thalamus .b 90 to 676 2 to 589   capped   588/588
(100 %)
2 diff
(99.7 %id)
BX395260 Neuroblastoma Cot 50-normalized .b 90 to 1109 1 to 1017       1017/1019
(99 %)
12 diff
(98.9 %id)
DA119655 cerebellum .b 91 to 650 2 to 563   capped   562/562
(100 %)
3 diff
(99.5 %id)
DN999703   .b 91 to 769 1 to 677       677/681
(99 %)
8 diff
(98.9 %id)
DA393326 thalamus .b 92 to 674 2 to 584   capped   583/583
(100 %)
4 diff
(99.4 %id)
DA204306 brain .b 93 to 680 2 to 589   capped   588/588
(100 %)
0 diff
(100 %id)
BG325468 Kidney, renal cell adenocarcinoma .b 94 to 898 1 to 802       800/887
(90 %)
23 diff
(97.5 %id)
BI914751 brain .b 94 to 808 1 to 725       725/725
(100 %)
14 diff
(98.1 %id)
BX342233   .b 95 to 1181 1 to 1080       1080/1089
(99 %)
13 diff
(98.9 %id)
BX386724   .b 95 to 783 1 to 689       689/689
(100 %)
1 diff
(99.9 %id)
BX343035   .b 95 to 684 1 to 593       593/593
(100 %)
5 diff
(99.2 %id)
BI820099 pooled brain, lung, testis .b 95 to 921 1 to 829       829/852
(97 %)
8 diff
(99.1 %id)
BI909141 leukocyte .b 95 to 978 1 to 877       877/877
(100 %)
19 diff
(97.9 %id)
TI_57199809   .b 95 to 921 67 to 895       829/918
(90 %)
12 diff
(98.7 %id)
TI_57236705   .b 95 to 978 30 to 906       877/906
(96 %)
21 diff
(97.7 %id)
TI_57170333   .b 95 to 671 52 to 628       577/629
(91 %)
8 diff
(98.8 %id)
TI_57244087   .b 96 to 808 35 to 757       723/757
(95 %)
9 diff
(98.9 %id)
BU552656 ovary, teratocarcinoma, cell line .b 97 to 922 1 to 828       828/888
(93 %)
12 diff
(98.7 %id)
BU181629 eye, retinoblastoma .b 98 to 1025 1 to 929       929/933
(99 %)
12 diff
(98.8 %id)
BG761745 melanotic melanoma, high MDR (cell line), skin .b 101 to 1022 1 to 922       922/924
(99 %)
28 diff
(97.0 %id)
BG768193 melanotic melanoma, high MDR (cell line), skin .b 101 to 686 1 to 612       588/991
(59 %)
43 diff
(95.7 %id)
BI825772 brain, medulla .b 101 to 671 1 to 571       571/572
(99 %)
12 diff
(98.0 %id)
BF206023 muscle, rhabdomyosarcoma .b 102 to 715 1 to 622       622/622
(100 %)
15 diff
(97.6 %id)
BG826603 muscle, rhabdomyosarcoma .b 102 to 742 1 to 640       640/641
(99 %)
11 diff
(98.3 %id)
BG827305 muscle, rhabdomyosarcoma .b 102 to 807 1 to 715       715/779
(91 %)
19 diff
(97.6 %id)
BI114215 muscle, rhabdomyosarcoma .b 102 to 838 1 to 766       702/799
(87 %)
51 diff
(93.7 %id)
AL523257 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 103 to 1025 1 to 923       923/923
(100 %)
2 diff
(99.8 %id)
BM475785 embryonal carcinoma, cell line, testis .b 103 to 490 1 to 401       401/986
(40 %)
22 diff
(97.8 %id)
BM738015 Ascites, stomach .b 103 to 594 1 to 493       493/493
(100 %)
1 diff
(99.8 %id)
BI905923 leukocyte .b 104 to 916 1 to 814       814/860
(94 %)
8 diff
(99.1 %id)
TI_57232061   .b 104 to 916 28 to 841       814/887
(91 %)
14 diff
(98.5 %id)
BX425362 neuroblastoma .b 106 to 867 1 to 762       762/904
(84 %)
21 diff
(97.7 %id)
CN255922 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 107 to 811 1 to 705       705/705
(100 %)
0 diff
(100 %id)
CN255934 embryonic stem cells, cell lines H1, H7, andH9 .b 113 to 815 1 to 704       704/706
(99 %)
2 diff
(99.8 %id)
BU182283 eye, retinoblastoma .b 116 to 901 11 to 803       793/905
(87 %)
15 diff
(98.4 %id)
TI_57183089   .b 117 to 764 31 to 678       648/678
(95 %)
7 diff
(99.0 %id)
BX341394   .b 118 to 958 1 to 841       841/841
(100 %)
0 diff
(100 %id)
BM473344 leiomyosarcoma, uterus .b 118 to 815 74 to 771       698/1372
(50 %)
11 diff
(99.2 %id)
BE295338 muscle, rhabdomyosarcoma .b 121 to 785 1 to 658       658/661
(99 %)
11 diff
(98.4 %id)
BE299797 muscle, rhabdomyosarcoma .b 122 to 884 1 to 762       762/762
(100 %)
12 diff
(98.5 %id)
BI771545 pooled lung and spleen .b 123 to 764 1 to 642       642/642
(100 %)
1 diff
(99.9 %id)
CN255924 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 127 to 815 1 to 688       688/697
(98 %)
2 diff
(99.8 %id)
DN998976 bone marrow .b 131 to 839 1 to 709       709/709
(100 %)
7 diff
(99.1 %id)
AL136925 uterus .b 135 to 3431 1 to 3297 exact tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 3297/3297
(100 %)
1 diff
(100.0 %id)
BM450842 eye, retinoblastoma .b 135 to 891 1 to 760       760/863
(88 %)
37 diff
(95.8 %id)
BI256871 cervical carcinoma cell line, cervix .b 136 to 946 1 to 813       813/813
(100 %)
8 diff
(99.1 %id)
AL536653 brain, fetal brain .b 138 to 1084 1 to 946       946/950
(99 %)
5 diff
(99.5 %id)
BX402441 Placenta Cot 25-normalized .b 139 to 1149 1 to 1002       1002/1010
(99 %)
13 diff
(98.8 %id)
TI_154197822   .b 139 to 919 98 to 868       771/947
(81 %)
14 diff
(98.6 %id)
BX379520 Placenta Cot 25-normalized .b 140 to 1181 1 to 1028       1028/1036
(99 %)
24 diff
(97.7 %id)
CN255930 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 144 to 360 1 to 217       217/217
(100 %)
2 diff
(99.1 %id)
CN255938 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 144 to 815 1 to 670       670/673
(99 %)
5 diff
(99.3 %id)
TI_154196190   .b 145 to 1022 22 to 896       875/1087
(80 %)
18 diff
(98.4 %id)
BQ694506 adipose .b 147 to 302 1 to 156       156/156
(100 %)
1 diff
(99.4 %id)
BU849860 ovary, teratocarcinoma, cell line .b 148 to 1031 1 to 884       884/909
(97 %)
7 diff
(99.3 %id)
BX352982 Neuroblastoma Cot 10-normalized .b 149 to 916 1 to 768       768/768
(100 %)
2 diff
(99.8 %id)
BE780931.
matches multiple genes
eye, Eye, retinoblastoma, retinoblastoma .b 149 to 922 1 to 768   available from MGC, Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base), also hits gene CPD 768/827
(92 %)
13 diff
(98.5 %id)
CN255936 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 156 to 812 1 to 656       656/656
(100 %)
4 diff
(99.4 %id)
CN255937 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 158 to 815 1 to 658       658/660
(99 %)
1 diff
(99.9 %id)
BE274905 melanotic melanoma, skin .b 248 to 1000 1 to 748       748/982
(76 %)
14 diff
(98.6 %id)
BG767480 melanotic melanoma, high MDR (cell line), skin .b 261 to 938 1 to 678       678/678
(100 %)
5 diff
(99.3 %id)
BE273857 Kidney, renal cell adenocarcinoma .b 262 to 960 1 to 694       694/697
(99 %)
11 diff
(98.5 %id)
BG770343 melanotic melanoma, high MDR (cell line), skin .b 279 to 997 23 to 751       704/753
(93 %)
44 diff
(94.2 %id)
AW249044 lung, small cell carcinoma .b 291 to 859 1 to 570       570/570
(100 %)
9 diff
(98.5 %id)
CN255918 embryonic stem cells, cell lines H1, H7, andH9 .b 314 to 816 1 to 502       502/502
(100 %)
1 diff
(99.9 %id)
CF125432 Chondrosarcoma Lung Metastasis cell lines, lung .b 335 to 1031 1 to 698       698/698
(100 %)
1 diff
(99.9 %id)
TI_154187082   .b 335 to 1052 49 to 767       719/719
(100 %)
1 diff
(99.9 %id)
BU856392 ovary, teratocarcinoma, cell line .b 352 to 815 1 to 467       467/1192
(39 %)
11 diff
(99.1 %id)
CN255921 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 402 to 618 8 to 224       217/224
(96 %)
8 diff
(96.5 %id)
CO249868 Chondrosarcoma Lung Metastasis cell lines, lung .b 409 to 967 36 to 594       559/781
(71 %)
21 diff
(97.4 %id)
BE159471 head_neck .b 412 to 972 17 to 577       561/589
(95 %)
9 diff
(98.5 %id)
BU189524 melanotic melanoma, skin .b 422 to 1182 1 to 765       765/895
(85 %)
21 diff
(97.7 %id)
CF125866 Chondrosarcoma Lung Metastasis cell lines, lung .b 422 to 1022 1 to 601       601/601
(100 %)
2 diff
(99.7 %id)
CF126028 Chondrosarcoma Lung Metastasis cell lines, lung .b 422 to 1074 1 to 653       653/653
(100 %)
0 diff
(100 %id)
TI_154187322   .b 422 to 1210 127 to 910       784/787
(99 %)
17 diff
(97.9 %id)
TI_154187514   .b 422 to 1133 131 to 837       707/925
(76 %)
5 diff
(99.5 %id)
BI871360 adenocarcinoma, cell line, Liver .b 425 to 1241 1 to 817       817/817
(100 %)
3 diff
(99.7 %id)
TI_57228422   .b 425 to 1241 51 to 867       817/817
(100 %)
3 diff
(99.7 %id)
CO399518 Chondrosarcoma Lung Metastasis cell lines, lung .b 429 to 1022 24 to 615       592/752
(78 %)
15 diff
(98.1 %id)
CN255935 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 447 to 998 1 to 551       551/551
(100 %)
3 diff
(99.5 %id)
EC486768 Prostate .b 448 to 546 1 to 99       99/99
(100 %)
7 diff
(93.0 %id)
BG421121 Kidney, renal cell adenocarcinoma .b 448 to 1037 1 to 593       593/594
(99 %)
5 diff
(99.2 %id)
CN255939 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 450 to 1208 1 to 761       761/761
(100 %)
3 diff
(99.7 %id)
EC473570 Prostate .b 456 to 541 13 to 98       86/98
(87 %)
6 diff
(93.9 %id)
TI_154196963   .b 491 to 1182 85 to 777       693/1044
(66 %)
19 diff
(98.2 %id)
TI_154196935   .b 515 to 1339 19 to 837       819/1068
(76 %)
15 diff
(98.6 %id)
BG748184 eye, normal pigmented retinal epithelium .b 520 to 1059 1 to 556       527/556
(94 %)
25 diff
(95.6 %id)
BQ057999 lymph, lymphoma, cell line .b 524 to 1345 1 to 833       833/1075
(77 %)
18 diff
(98.4 %id)
BQ061235 lymph, lymphoma, cell line .b 524 to 1469 1 to 953       951/1050
(90 %)
30 diff
(97.2 %id)
BQ063673 lymph, lymphoma, cell line .b 524 to 1351 1 to 827       827/1036
(79 %)
12 diff
(98.9 %id)
BQ642626 lymph, lymphoma, cell line .b 524 to 1431 1 to 910       910/915
(99 %)
6 diff
(99.4 %id)
BX341226   .b 531 to 1070 1 to 540       540/540
(100 %)
0 diff
(100 %id)
TI_154195687   .b 538 to 1299 1 to 760       760/1022
(74 %)
20 diff
(98.1 %id)
BI457543 epithelioid carcinoma cell line, Pancreas .b 541 to 1345 1 to 805       805/836
(96 %)
21 diff
(97.5 %id)
TI_45133646   .b 542 to 1345 57 to 860       804/835
(96 %)
20 diff
(97.7 %id)
CO249700 Chondrosarcoma Lung Metastasis cell lines, lung .b 550 to 1263 1 to 705       705/812
(86 %)
18 diff
(97.8 %id)
CO250135 Chondrosarcoma Lung Metastasis cell lines, lung .b 634 to 1345 1 to 707       707/812
(87 %)
11 diff
(98.7 %id)
BE268548 Burkitt lymphoma, lymph .b 685 to 1296 26 to 638       613/638
(96 %)
10 diff
(98.5 %id)
BE397467 Burkitt lymphoma, lymph .b 685 to 1457 17 to 788       772/865
(89 %)
23 diff
(97.4 %id)
BE397618 Burkitt lymphoma, lymph .b 685 to 1405 24 to 741       719/742
(96 %)
16 diff
(97.9 %id)
BE514254 Burkitt lymphoma, lymph .b 685 to 1293 19 to 628       610/629
(96 %)
10 diff
(98.5 %id)
BG335194 choriocarcinoma, placenta .b 688 to 1490 1 to 804       806/1103
(73 %)
20 diff
(98.2 %id)
BE397851 Burkitt lymphoma, lymph .b 722 to 1389 18 to 686       671/690
(97 %)
16 diff
(97.7 %id)
BE703216 nervous_normal .b 736 to 1217 488 to 8       481/489
(98 %)
4 diff
(99.2 %id)
CF125907 Chondrosarcoma Lung Metastasis cell lines, lung .b 766 to 1475 1 to 709       709/709
(100 %)
1 diff
(99.9 %id)
TI_154187380   .b 766 to 1650 115 to 987       873/958
(91 %)
17 diff
(98.3 %id)
TI_154196082   .b 777 to 1629 10 to 859       850/1066
(79 %)
66 diff
(93.9 %id)
TI_154197714   .b 781 to 1583 68 to 862       795/970
(81 %)
34 diff
(96.5 %id)
CN255920 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 811 to 987 1 to 176       176/176
(100 %)
4 diff
(97.8 %id)
AL042867 testis .b 827 to 1440 1 to 616       616/620
(99 %)
4 diff
(99.4 %id)
AW580196 head_neck .b 836 to 1375 550 to 4       545/550
(99 %)
20 diff
(96.4 %id)
AW606713 head_neck .b 841 to 993 1 to 152       152/152
(100 %)
3 diff
(98.1 %id)
CO248215 Chondrosarcoma Lung Metastasis cell lines, lung .b 858 to 1482 47 to 670       624/798
(78 %)
20 diff
(97.5 %id)
DR158080 human embryonic stem cells differentiated toan early endodermal cell type .b 875 to 1671 1 to 797       797/797
(100 %)
2 diff
(99.8 %id)
BI752116 brain .b 882 to 1695 1 to 814       814/814
(100 %)
5 diff
(99.4 %id)
TI_57215215   .b 882 to 1695 66 to 879       814/879
(92 %)
11 diff
(98.8 %id)
BG766976 melanotic melanoma, high MDR (cell line), skin .b 888 to 1586 1 to 705       705/705
(100 %)
12 diff
(98.3 %id)
BE537183 cervix .b 915 to 1583 1 to 678       678/748
(90 %)
24 diff
(96.8 %id)
BU556986 ovary, teratocarcinoma, cell line .b 924 to 1739 1 to 815       815/943
(86 %)
8 diff
(99.2 %id)
BU184887 melanotic melanoma, cell line, skin .b 979 to 1756 1 to 784       784/933
(84 %)
18 diff
(98.1 %id)
BE159719 head_neck .b 1038 to 1286 25 to 274       250/283
(88 %)
7 diff
(97.6 %id)
CK000317 mixed .b 1062 to 1764 8 to 711       704/779
(90 %)
11 diff
(98.6 %id)
TI_154195081   .b 1074 to 2052 1 to 972       972/1097
(88 %)
22 diff
(98.0 %id)
TI_154195268   .b 1077 to 2217 4 to 1132       1129/1184
(95 %)
36 diff
(97.0 %id)
BE159567 head_neck .b 1092 to 1266 11 to 184       174/184
(94 %)
6 diff
(96.8 %id)
DR157408 human embryonic stem cells differentiated toan early endodermal cell type .b 1103 to 1736 1 to 634       634/634
(100 %)
1 diff
(99.9 %id)
AI909619 breast .b 1118 to 1450 333 to 1       333/362
(91 %)
3 diff
(99.2 %id)
BQ710354 Spleen .b 1130 to 1762 1 to 635       635/973
(65 %)
4 diff
(99.6 %id)
BG994307 head_neck .b 1136 to 1360 1 to 221       221/225
(98 %)
13 diff
(94.3 %id)
BU158853 embryonal carcinoma, cell line, testis .b 1157 to 1757 1 to 604       604/910
(66 %)
8 diff
(99.2 %id)
CN255917 embryonic stem cells, cell lines H1, H7, andH9 .b 1169 to 1756 6 to 592       585/592
(98 %)
8 diff
(98.7 %id)
TI_59394419   .b 1183 to 1903 89 to 818       730/741
(98 %)
18 diff
(97.6 %id)
BM016039 breast, mammary adenocarcinoma, cell line .b 1184 to 1903 1 to 729       729/740
(98 %)
18 diff
(97.6 %id)
CN255923 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 1196 to 1740 5 to 548       542/548
(98 %)
6 diff
(99.0 %id)
BQ711563 Spleen .b 1211 to 1765 1 to 560       560/999
(56 %)
14 diff
(98.6 %id)
BF310640 brain, neuroblastoma .b 1219 to 1750 1 to 533       533/533
(100 %)
6 diff
(98.9 %id)
BI197839 brain, neuroblastoma .b 1219 to 1765 1 to 555       555/1211
(45 %)
15 diff
(98.8 %id)
CN255919 embryonic stem cells, DMSO-treated H9 cellline .b 1222 to 1734 1 to 513       513/513
(100 %)
0 diff
(100 %id)
BQ949687 large cell carcinoma, lung .b 1242 to 2000 1 to 761       761/943
(80 %)
5 diff
(99.5 %id)
BU507192 leiomyosarcoma, uterus .b 1276 to 1953 1 to 689       689/841
(81 %)
25 diff
(97.1 %id)
EC471508 Prostate .b 1282 to 1375 1 to 94       92/96
(95 %)
6 diff
(93.8 %id)
BQ711111 Spleen .b 1342 to 1973 1 to 634       634/883
(71 %)
22 diff
(97.6 %id)
BG911342 anaplastic oligodendroglioma with 1p/19qloss, brain .b 1346 to 1994 1 to 654       654/742
(88 %)
13 diff
(98.3 %id)
BF958880 nervous_normal .b 1369 to 1770 426 to 12       426/426
(100 %)
62 diff
(85.5 %id)
TI_154194969   .b 1375 to 2172 49 to 840       792/1011
(78 %)
15 diff
(98.6 %id)
BF958881 nervous_normal .b 1392 to 1762 384 to 18       366/384
(95 %)
0 diff
(100 %id)
BF091887 testis_normal .b 1403 to 1764 1 to 362       362/374
(96 %)
4 diff
(99.0 %id)
CO246848 Chondrosarcoma Lung Metastasis cell lines, lung .b 1403 to 1761 1 to 359       359/730
(49 %)
7 diff
(99.1 %id)
BM459036 melanotic melanoma, skin .b 1405 to 2168 1 to 764       764/1036
(73 %)
21 diff
(98.0 %id)
BG767415 melanotic melanoma, high MDR (cell line), skin .b 1430 to 2146 1 to 717       717/719
(99 %)
3 diff
(99.6 %id)
BG769773 melanotic melanoma, high MDR (cell line), skin .b 1430 to 2173 1 to 749       749/807
(92 %)
18 diff
(97.8 %id)
BI085213 astrocytoma grade IV, cell line, brain .b 1454 to 2117 1 to 672       672/693
(96 %)
17 diff
(97.6 %id)
BM801351 duodenal adenocarcinoma, cell line, small intestine .b 1461 to 2000 40 to 579       540/1046
(51 %)
20 diff
(98.1 %id)
BU172788 melanotic melanoma, skin .b 1484 to 1988 2 to 508       507/1056
(48 %)
18 diff
(98.3 %id)
BG121726 adenocarcinoma, cell line, Liver .b 1494 to 2166 1 to 674       674/1118
(60 %)
7 diff
(99.4 %id)
BM564250 blood, natural killer cells, cell line .b 1496 to 2326 1 to 840       840/1127
(74 %)
40 diff
(96.5 %id)
BE159661 head_neck .b 1498 to 2042 19 to 573       555/573
(96 %)
17 diff
(97.1 %id)
BG831562 epithelioid carcinoma cell line, Pancreas .b 1521 to 2333 1 to 809       809/826
(97 %)
31 diff
(96.3 %id)
BF092966 testis_normal .b 1526 to 1836 307 to 1       307/307
(100 %)
5 diff
(98.4 %id)
BI049994 placenta_normal .b 1526 to 1868 14 to 357       344/377
(91 %)
14 diff
(96.3 %id)
BF093238 testis_normal .b 1544 to 1816 274 to 3       272/274
(99 %)
1 diff
(99.7 %id)
BI160836 epithelioid carcinoma cell line, Pancreas .b 1548 to 2173 1 to 627       627/947
(66 %)
11 diff
(98.9 %id)
DA059309 cerebellum .b 1566 to 2102 2 to 538   capped   537/537
(100 %)
0 diff
(100 %id)
DA903150   .b 1579 to 1985 2 to 408   capped   407/407
(100 %)
0 diff
(100 %id)
CB156231 brain .b 1580 to 2068 1 to 489       489/489
(100 %)
2 diff
(99.6 %id)
CF121352 CNCAP(3)T-225 cell line, Prostate .b 1588 to 2206 1 to 619       619/619
(100 %)
6 diff
(99.1 %id)
CF121384 CNCAP(3)T-225 cell line, Prostate .b 1588 to 2189 1 to 603       603/603
(100 %)
8 diff
(98.7 %id)
CF121403 CNCAP(3)T-225 cell line, Prostate .b 1588 to 2206 1 to 618       618/619
(99 %)
9 diff
(98.6 %id)
CF121428 CNCAP(3)T-225 cell line, Prostate .b 1588 to 2168 1 to 581       581/583
(99 %)
12 diff
(98.0 %id)
BM562248 amelanotic melanoma, cell line, skin .b 1589 to 2008 34 to 453       420/1032
(40 %)
19 diff
(98.2 %id)
BM423897 amelanotic melanoma, cell line, skin .b 1589 to 2268 34 to 709       676/1044
(64 %)
31 diff
(97.1 %id)
BM423901 amelanotic melanoma, cell line, skin .b 1589 to 2236 34 to 688       655/1071
(61 %)
17 diff
(98.5 %id)
T85630 liver and spleen .b 1592 to 1727 1 to 139       139/142
(97 %)
7 diff
(95.1 %id)
TI_154180388   .b 1594 to 2466 69 to 931       863/951
(90 %)
23 diff
(97.6 %id)
TI_154180430   .b 1594 to 2333 75 to 817       743/992
(74 %)
17 diff
(98.3 %id)
TI_154180461   .b 1594 to 2329 76 to 802       727/867
(83 %)
22 diff
(97.5 %id)
TI_154180503   .b 1594 to 2312 68 to 778       711/922
(77 %)
24 diff
(97.4 %id)
BM917172 blood, natural killer cells, cell line .b 1596 to 2175 91 to 661       571/1036
(55 %)
20 diff
(98.1 %id)
BE159644 head_neck .b 1613 to 1997 1 to 400       400/445
(89 %)
32 diff
(92.9 %id)
R87211 brain .b 1613 to 1992 1 to 381       383/393
(97 %)
12 diff
(97.0 %id)
CR595429 Neuroblastoma Cot 25-normalized .b 1624 to 3403 1 to 1780       1780/1780
(100 %)
0 diff
(100 %id)
AL527222 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 1624 to 2497 1 to 876   fully sequenced,   876/876
(100 %)
4 diff
(99.6 %id)
R11896 whole brain .b 1655 to 1999 1 to 345       345/345
(100 %)
3 diff
(99.2 %id)
BE743531 adenocarcinoma cell line, ovary .b 1666 to 2227 1 to 562       562/562
(100 %)
4 diff
(99.3 %id)
CN255933 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 1675 to 2238 1 to 564       564/564
(100 %)
0 diff
(100 %id)
R13759 whole brain .b 1696 to 1953 1 to 259     Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 259/264
(98 %)
3 diff
(98.9 %id)
BX335167 Placenta Cot 25-normalized .b 1700 to 2466 1 to 774       774/774
(100 %)
19 diff
(97.6 %id)
BI254163 cervical carcinoma cell line, cervix .b 1700 to 2291 1 to 599       599/858
(69 %)
17 diff
(98.1 %id)
EC484548 Prostate .b 1709 to 1813 1 to 105       105/105
(100 %)
6 diff
(94.3 %id)
BE548564 cervical carcinoma cell line, cervix .b 1723 to 2465 1 to 724       724/774
(93 %)
34 diff
(95.7 %id)
BM548436 brain, hippocampus .b 1725 to 2173 10 to 458       449/1303
(34 %)
13 diff
(99.1 %id)
EC467592 Prostate .b 1726 to 1825 1 to 99       99/102
(97 %)
0 diff
(100 %id)
EC554060 Prostate .b 1727 to 1822 1 to 91       91/95
(95 %)
9 diff
(90.6 %id)
EC554474 Prostate .b 1729 to 1829 1 to 100       100/100
(100 %)
4 diff
(96.0 %id)
CA488155   .b 1755 to 2556 1 to 804       804/896
(89 %)
6 diff
(99.4 %id)
CB045212 colon, juvenile granulosa tumor .b 1761 to 2309 1 to 549     Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 549/549
(100 %)
6 diff
(99.0 %id)
BQ070936 brain, neuroblastoma, cell line .b 1771 to 2564 1 to 793       793/1023
(77 %)
14 diff
(98.7 %id)
BM010436 amelanotic melanoma, cell line, skin .b 1793 to 2155 1 to 369       369/587
(62 %)
14 diff
(97.7 %id)
TI_59385254   .b 1794 to 2155 95 to 462       368/586
(62 %)
13 diff
(97.8 %id)
BM562258 amelanotic melanoma, cell line, skin .b 1796 to 2556 1 to 759       759/1033
(73 %)
11 diff
(99.0 %id)
BF686781 leiomyosarcoma cell line, uterus .b 1813 to 2556 1 to 735       735/952
(77 %)
34 diff
(96.5 %id)
N34593 melanocyte .b 1826 to 2198 1 to 372       372/372
(100 %)
12 diff
(96.8 %id)
CD636091   .b 1831 to 2567 16 to 756       741/756
(98 %)
14 diff
(98.2 %id)
CD672067 eye, Iris .b 1878 to 2462 1 to 585     Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 585/585
(100 %)
1 diff
(99.9 %id)
AW675368 cervical carcinoma cell line, cervix .b 1878 to 2324 1 to 447       447/447
(100 %)
4 diff
(99.2 %id)
AL045265 testis .b 1900 to 2391 1 to 492       492/492
(100 %)
0 diff
(100 %id)
BU146849 dorsal root ganglia .b 1900 to 2678 1 to 782       782/876
(89 %)
11 diff
(98.8 %id)
BQ228659 melanotic melanoma, skin .b 1903 to 2673 11 to 793       783/860
(91 %)
39 diff
(95.5 %id)
DA012170 adrenal gland .b 1923 to 2388 2 to 471   capped   470/473
(99 %)
7 diff
(98.6 %id)
DA016064 adrenal gland .b 1923 to 2490 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
CR975001 T-Lymphocytes .b 1933 to 2413 1 to 481       481/485
(99 %)
1 diff
(99.8 %id)
CK819897 Islets of Langerhans, Pancreas .b 1937 to 2495 1 to 559       559/559
(100 %)
0 diff
(100 %id)
BQ422163 embryonal carcinoma, cell line, testis .b 1942 to 2665 1 to 728       728/909
(80 %)
21 diff
(97.7 %id)
BU184981 melanotic melanoma, cell line, skin .b 1942 to 2678 1 to 737       737/901
(81 %)
1 diff
(99.9 %id)
BU195873 melanotic melanoma, cell line, skin .b 1942 to 2787 1 to 851       851/910
(93 %)
30 diff
(96.8 %id)
BQ683755 melanotic melanoma, cell line, skin .b 1942 to 2795 1 to 865       865/976
(88 %)
32 diff
(96.8 %id)
BU535647 adenocarcinoma, cell line, breast .b 1945 to 2677 1 to 735       735/919
(79 %)
9 diff
(99.1 %id)
BU860158 adenocarcinoma, cell line, breast .b 1945 to 2466 1 to 516       516/832
(62 %)
7 diff
(99.2 %id)
CR980082 T-Lymphocytes .b 1945 to 2503 1 to 562       562/565
(99 %)
9 diff
(98.5 %id)
BM142092 Islets of Langerhans, Pancreas .b 1953 to 2486 1 to 534       534/534
(100 %)
1 diff
(99.9 %id)
BI856169 breast, mammary adenocarcinoma, cell line .b 1961 to 2761 1 to 821       819/883
(92 %)
45 diff
(95.0 %id)
TI_57186028   .b 1961 to 2761 55 to 875   AAA   819/873
(93 %)
45 diff
(94.9 %id)
CB124131 Liver .b 2049 to 2583 1 to 535       535/535
(100 %)
0 diff
(100 %id)
CX785641 human embryonic stem cells .b 2075 to 2912 1 to 838       838/840
(99 %)
1 diff
(99.9 %id)
CR980058 T-Lymphocytes .b 2080 to 2784 1 to 705       705/705
(100 %)
0 diff
(100 %id)
BG390400 embryonal carcinoma, cell line, testis .b 2093 to 2659 1 to 570       570/570
(100 %)
3 diff
(99.5 %id)
CR991199 T-Lymphocytes .b 2104 to 2320 1 to 218       218/220
(99 %)
2 diff
(99.1 %id)
BU170165 epithelioid carcinoma, Pancreas .b 2105 to 2861 1 to 762       760/886
(85 %)
16 diff
(98.2 %id)
CN255916 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 2114 to 2630 1 to 517       517/517
(100 %)
6 diff
(98.9 %id)
BG338228 leiomyosarcoma cell line, uterus .b 2118 to 2952 1 to 828       828/828
(100 %)
15 diff
(98.2 %id)
BU174549 ductal carcinoma, cell line, Pancreas .b 2118 to 2974 31 to 903       870/937
(92 %)
28 diff
(97.1 %id)
BU849568 ovary, teratocarcinoma, cell line .b 2130 to 2866 1 to 737       737/901
(81 %)
7 diff
(99.3 %id)
BU538120 adenocarcinoma, cell line, breast .b 2142 to 2864 1 to 724       724/912
(79 %)
2 diff
(99.8 %id)
BU846014 ovary, teratocarcinoma, cell line .b 2163 to 2958 1 to 804       800/945
(84 %)
19 diff
(98.0 %id)
BE910556 epithelioid carcinoma, Pancreas .b 2167 to 2643 15 to 511       497/1149
(43 %)
31 diff
(97.4 %id)
CD636092   .b 2215 to 2877 665 to 4       662/665
(99 %)
1 diff
(99.9 %id)
BE311475 Kidney, renal cell adenocarcinoma .b 2233 to 2906 1 to 666       668/722
(92 %)
13 diff
(98.2 %id)
BQ217442 melanotic melanoma, skin .b 2239 to 2999 1 to 768       768/949
(80 %)
10 diff
(99.0 %id)
BQ647445 hepatocellular carcinoma, cell line, Liver .b 2255 to 3166 19 to 931       912/972
(93 %)
25 diff
(97.5 %id)
BQ278113 ovary, teratocarcinoma, cell line .b 2268 to 3166 1 to 908       908/1063
(85 %)
6 diff
(99.5 %id)
BU553339 ovary, teratocarcinoma, cell line .b 2268 to 3125 1 to 870       870/880
(98 %)
29 diff
(96.8 %id)
BU557280 ovary, teratocarcinoma, cell line .b 2268 to 3100 1 to 835       835/846
(98 %)
4 diff
(99.6 %id)
CN255927 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 2277 to 2734 6 to 463       458/463
(98 %)
6 diff
(98.8 %id)
BF311374 brain, neuroblastoma .b 2277 to 3011 1 to 731       731/812
(90 %)
15 diff
(98.2 %id)
BF333906 colon .b 2296 to 2794 1 to 499       499/499
(100 %)
1 diff
(99.8 %id)
TI_57228906   .b 2306 to 3160 89 to 943       855/856
(99 %)
13 diff
(98.5 %id)
BI869844 adenocarcinoma, cell line, Liver .b 2307 to 3160 1 to 854       854/855
(99 %)
13 diff
(98.5 %id)
BI085286 astrocytoma grade IV, cell line, brain .b 2313 to 3116 1 to 804       804/804
(100 %)
4 diff
(99.6 %id)
CB044192 colon, juvenile granulosa tumor .b 2314 to 2891 11 to 588     Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 578/588
(98 %)
0 diff
(100 %id)
BF569274 Kidney, renal carcinoma (ascites) .b 2319 to 3007 1 to 685       689/686
(100 %)
11 diff
(98.4 %id)
H57568 liver and spleen .b 2383 to 2547 7 to 171       165/172
(95 %)
4 diff
(97.7 %id)
BE255864 eye, retinoblastoma .b 2383 to 3036 20 to 669       654/672
(97 %)
16 diff
(97.7 %id)
BF116194 fibrotheoma, ovary .b 2387 to 3076 1 to 690     Submitted on the opposite strand 690/690
(100 %)
0 diff
(100 %id)
BM472437 melanotic melanoma, skin .b 2391 to 2935 8 to 554       545/1103
(49 %)
11 diff
(99.1 %id)
CN255925 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 2397 to 3022 7 to 631       625/631
(99 %)
7 diff
(98.9 %id)
CN255928 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 2398 to 3101 1 to 703       703/703
(100 %)
7 diff
(99.1 %id)
BG252568 adenocarcinoma, cell line, Liver .b 2405 to 3165 1 to 754       754/754
(100 %)
11 diff
(98.6 %id)
BQ671616 epidermoid carcinoma, cell line, salivary gland .b 2406 to 3171 1 to 770       770/978
(78 %)
27 diff
(97.3 %id)
BQ669775 epidermoid carcinoma, cell line, salivary gland .b 2406 to 3132 1 to 729       729/1012
(72 %)
11 diff
(99.0 %id)
BQ669294 epidermoid carcinoma, cell line, salivary gland .b 2406 to 3130 1 to 727       727/967
(75 %)
17 diff
(98.3 %id)
AL566422 brain, fetal brain .b 2411 to 3339 922 to 1       922/936
(98 %)
20 diff
(97.9 %id)
BQ675841 epidermoid carcinoma, cell line, salivary gland .b 2429 to 3194 1 to 779       779/871
(89 %)
21 diff
(97.6 %id)
CN255929 embryonic stem cells, DMSO-treated H9 cellline .b 2433 to 2705 1 to 273       273/273
(100 %)
0 diff
(100 %id)
CN255931 embryonic stem cells, cell lines H1, H7, andH9 .b 2450 to 3065 1 to 616       616/616
(100 %)
1 diff
(99.9 %id)
BM695069 eye, human retina .b 2457 to 2824 1 to 368     Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 368/368
(100 %)
1 diff
(99.8 %id)
AL562851 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 2466 to 3384 944 to 23   fully sequenced,   922/944
(97 %)
6 diff
(99.4 %id)
BX402440 Placenta Cot 25-normalized .b 2481 to 3409 917 to 1       917/986
(93 %)
26 diff
(97.4 %id)
T78562 liver and spleen .b 2492 to 2766 1 to 272       272/275
(98 %)
6 diff
(97.9 %id)
TI_154197767   .b 2525 to 3425 64 to 951       888/1064
(83 %)
35 diff
(96.8 %id)
TI_154196135   .b 2535 to 3344 1 to 802       802/1029
(77 %)
20 diff
(98.1 %id)
BG341346 B-cells, primary B-cells from tonsils (cell line) .b 2540 to 3267 1 to 717       717/758
(94 %)
20 diff
(97.4 %id)
BU539464 adenocarcinoma, cell line, breast .b 2544 to 3274 1 to 731       731/738
(99 %)
8 diff
(99.0 %id)
AA319101 adrenal gland .b 2555 to 2742 8 to 195       188/195
(96 %)
10 diff
(94.9 %id)
AL523256 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 2557 to 3384 854 to 29       826/854
(96 %)
28 diff
(96.8 %id)
BQ671628 epidermoid carcinoma, cell line, salivary gland .b 2608 to 2958 1 to 351       351/351
(100 %)
0 diff
(100 %id)
W69625 heart .b 2648 to 3000 1 to 354       354/381
(92 %)
5 diff
(98.7 %id)
BM707592 eye, RPE and Choroid .b 2664 to 3198 1 to 535       535/535
(100 %)
0 diff
(100 %id)
BM708087 eye, RPE and Choroid .b 2664 to 3125 1 to 462     Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 462/462
(100 %)
0 diff
(100 %id)
BM797003 Ascites, stomach .b 2670 to 3088 1 to 420       420/420
(100 %)
2 diff
(99.6 %id)
BX365637   .b 2676 to 3399 723 to 1       723/723
(100 %)
3 diff
(99.6 %id)
BU501040 eye, normal pigmented retinal epithelium .b 2686 to 3273 1 to 587       587/591
(99 %)
4 diff
(99.4 %id)
TI_59391518   .b 2706 to 3289 87 to 670       584/584
(100 %)
1 diff
(99.9 %id)
BM013615 breast, mammary adenocarcinoma, cell line .b 2707 to 3289 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
BG122000 adenocarcinoma, cell line, Liver .b 2719 to 3284 1 to 567       567/567
(100 %)
7 diff
(98.8 %id)
BI259908 cervical carcinoma cell line, cervix .b 2724 to 3336 1 to 614   AAA   614/705
(87 %)
3 diff
(99.6 %id)
BE900357 choriocarcinoma, placenta .b 2747 to 3274 1 to 530       530/537
(98 %)
3 diff
(99.5 %id)
BX343034   .b 2797 to 3398 612 to 7       602/612
(98 %)
16 diff
(97.4 %id)
N26712 melanocyte .b 3048 to 3431 390 to 1       390/390
(100 %)
12 diff
(97.0 %id)
R38604 whole brain .b 3093 to 3431 357 to 12   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 346/348
(99 %)
13 diff
(96.3 %id)
AW248605 lung, small cell carcinoma .b 3280 to 3431 166 to 15       152/179
(84 %)
0 diff
(100 %id)
CB044191 colon, juvenile granulosa tumor .b 3282 to 3434 202 to 50   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 153/153
(100 %)
6 diff
(96.1 %id)
CB045211 colon, juvenile granulosa tumor .b 3282 to 3431 166 to 17   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 150/150
(100 %)
0 diff
(100 %id)
BU731940 eye, RPE and Choroid .b 3282 to 3431 172 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 154/154
(100 %)
4 diff
(97.5 %id)
BM666852 eye, human retina .b 3282 to 3434 170 to 16   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 155/155
(100 %)
2 diff
(98.8 %id)
AW674761 cervical carcinoma cell line, cervix .b 3341 to 3434 94 to 1   tiling clone,   94/97
(96 %)
0 diff
(100 %id)
CD672066 eye, Iris .b 3345 to 3431 104 to 18   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 87/87
(100 %)
1 diff
(98.9 %id)
CD671215 eye, Iris .c 1 to 611 1 to 611   tiling clone, Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 611/611
(100 %)
0 diff
(100 %id)
CD671214 eye, Iris .c 1132 to 1187 72 to 17   tiling clone, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 56/70
(80 %)
0 diff
(100 %id)
BC111754 PCR rescued clones .d 1 to 2201 2201 to 1 C3R tiling clone, Submitted on the opposite strand 2201/2206
(99 %)
7 diff
(99.7 %id)
AA031995 uterus .d 2067 to 2516 1 to 450   tiling clone,   450/450
(100 %)
10 diff
(97.8 %id)
AA558479 germ cell tumor .d 2068 to 2488 421 to 1       421/427
(98 %)
12 diff
(97.2 %id)
AA985102 schizophrenic brain S-11 frontal lobe .d 2069 to 2496 429 to 1       429/436
(98 %)
18 diff
(95.9 %id)
AA569103 colon, colon tumor RER+ .d 2075 to 2516 442 to 1       442/442
(100 %)
6 diff
(98.7 %id)
EC540864 Prostate .d 2077 to 2146 13 to 82       70/82
(85 %)
6 diff
(92.7 %id)
BX358472 Placenta Cot 25-normalized .d 2081 to 2519 1 to 439   fully sequenced,   439/439
(100 %)
6 diff
(98.7 %id)
AL041550 testis .d 2094 to 2350 1 to 257       257/257
(100 %)
0 diff
(100 %id)
AA995684 2 pooled tumors (clear cell type), Kidney .d 2095 to 2374 300 to 23       278/300
(92 %)
0 diff
(100 %id)
EC507488 Prostate .d 2126 to 2215 1 to 87       87/87
(100 %)
2 diff
(97.8 %id)
AA643649 colon, colon tumor RER+ .d 2128 to 2515 385 to 1       385/385
(100 %)
25 diff
(93.6 %id)
AA833725   .d 2151 to 2517 368 to 2       367/368
(99 %)
0 diff
(100 %id)
AA524208 colon .d 2161 to 2521 361 to 1   tiling clone,   361/469
(76 %)
4 diff
(99.2 %id)
T96648 liver and spleen .d 2165 to 2517 358 to 2       357/358
(99 %)
0 diff
(100 %id)
T15973   .d 2184 to 2515 332 to 1       332/332
(100 %)
1 diff
(99.7 %id)
EC522116 Prostate .d 2194 to 2314 1 to 118       118/118
(100 %)
3 diff
(97.5 %id)
EC580044 Prostate .d 2200 to 2314 9 to 121       113/121
(93 %)
6 diff
(95.1 %id)
EC533382 Prostate .d 2220 to 2339 1 to 119       119/119
(100 %)
8 diff
(93.3 %id)
CN273458 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 2234 to 2376 1 to 143       143/143
(100 %)
2 diff
(98.7 %id)
H62073.
matches multiple genes
ovarian tumor, ovary .d 2249 to 2513 1 to 264     Submitted on the opposite strand, also hits gene ACVR2A 264/272
(97 %)
2 diff
(99.3 %id)
BX358471 Placenta Cot 25-normalized .d 2259 to 2464 209 to 1   fully sequenced,   209/209
(100 %)
8 diff
(96.2 %id)
BM723725 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .d 2293 to 2518 1 to 227   fully sequenced, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 227/227
(100 %)
9 diff
(96.1 %id)
AA418351 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 2295 to 2723 1 to 429   tiling clone,   429/429
(100 %)
5 diff
(98.9 %id)
AA834128 Kidney, kidney tumor .d 2323 to 2722 1 to 400   tiling clone,   400/400
(100 %)
4 diff
(99.0 %id)
AW293035   .d 2361 to 2515 179 to 23       157/179
(87 %)
0 diff
(100 %id)
BM675089 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .d 2361 to 2515 171 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 153/155
(98 %)
2 diff
(98.8 %id)
BY800303 eye .d 2363 to 2519 13 to 169       157/169
(92 %)
6 diff
(96.5 %id)
AA995845 germ cell tumor .d 2363 to 2518 181 to 26   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 156/156
(100 %)
2 diff
(98.8 %id)
AI298958 carcinoid, lung .d 2365 to 2515 151 to 1       151/151
(100 %)
0 diff
(100 %id)
AI279375 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 2365 to 2516 152 to 1       152/152
(100 %)
0 diff
(100 %id)
AI673187 colon, colonic mucosa from 3 patients with Crohn'sdisease .d 2365 to 2518 171 to 18   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 154/155
(99 %)
0 diff
(100 %id)
TI_154135159   .d 2365 to 2518 233 to 78   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 156/160
(97 %)
2 diff
(98.8 %id)
AI683915 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .d 2366 to 2518 174 to 22   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 153/153
(100 %)
0 diff
(100 %id)
AI689541 serous papillary carcinoma, high grade, 2pooled tumors, uterus .d 2366 to 2519 157 to 4       154/157
(98 %)
0 diff
(100 %id)
AI701042 adenocarcinoma, Pancreas .d 2366 to 2517 156 to 5       152/156
(97 %)
0 diff
(100 %id)
BM975573 lung, Primary Lung Cystic Fibrosis EpithelialCells .d 2366 to 2515 168 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 150/150
(100 %)
0 diff
(100 %id)
AI827964 anaplastic oligodendroglioma, brain .d 2367 to 2516 150 to 1       150/150
(100 %)
0 diff
(100 %id)
BE675026 B-cell, chronic lymphotic leukemia .d 2367 to 2517 152 to 2       151/152
(99 %)
0 diff
(100 %id)
BM982202 lung, Primary Lung Cystic Fibrosis EpithelialCells .d 2367 to 2518 168 to 16   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 153/153
(100 %)
1 diff
(99.4 %id)
CN478889 Human Lung Epithelial cells, lung .d 2367 to 2515 168 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 150/150
(100 %)
1 diff
(99.4 %id)
CA446695 Chondrosarcoma, Left Pubic Bone .d 2367 to 2515 168 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 150/150
(100 %)
1 diff
(99.4 %id)
CN479868 Knee, Osteoarthritic Cartilage .d 2367 to 2518 169 to 16   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 154/154
(100 %)
2 diff
(98.8 %id)
BM981973 lung, Primary Lung Cystic Fibrosis EpithelialCells .d 2368 to 2515 168 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 150/153
(98 %)
5 diff
(96.8 %id)
CA422391 cell lines, Chondrosarcoma .d 2368 to 2518 174 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 156/156
(100 %)
7 diff
(95.6 %id)
AI973181 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .d 2372 to 2518 172 to 26   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 147/147
(100 %)
4 diff
(97.3 %id)
AI673232 colon, colonic mucosa from 3 patients with Crohn'sdisease .d 2373 to 2517 149 to 5       145/149
(97 %)
0 diff
(100 %id)
AI869595 anaplastic oligodendroglioma, brain .d 2373 to 2512 142 to 3       140/142
(98 %)
0 diff
(100 %id)
BU620042 Cell Line, Chondrosarcoma .d 2373 to 2515 162 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 144/144
(100 %)
1 diff
(99.4 %id)
BU618079 Bone, Subchondral Bone .d 2375 to 2515 160 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 142/142
(100 %)
1 diff
(99.3 %id)
CA416588 Chondrosarcoma Cell line .d 2376 to 2515 159 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 141/141
(100 %)
2 diff
(98.6 %id)
BQ014346 Chondrosarcoma, Left Pubic Bone .d 2384 to 2518 151 to 16   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 136/136
(100 %)
2 diff
(98.6 %id)
AA811319 germinal center B cell .d 2387 to 2518 169 to 38   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 132/132
(100 %)
1 diff
(99.3 %id)
AA446315.
matches multiple genes
  .d 2389 to 2519 133 to 3     also hits gene CSNK1D 131/133
(98 %)
0 diff
(100 %id)
AI089828 brain, glioblastoma (pooled) .d 2391 to 2517 127 to 1       127/127
(100 %)
0 diff
(100 %id)
AI608687 brain, tumor, 5 pooled (see description) .d 2407 to 2519 115 to 3       113/115
(98 %)
0 diff
(100 %id)
BM681910 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .d 2418 to 2518 116 to 16   fully sequenced, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 101/101
(100 %)
2 diff
(98.1 %id)
AI125739   .d 2422 to 2518 112 to 16   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 97/97
(100 %)
0 diff
(100 %id)
BG912317 anaplastic oligodendroglioma with 1p/19qloss, brain .e 1 to 698 10 to 703   tiling clone,   694/703
(98 %)
10 diff
(98.6 %id)
BX342232   .e 2 to 1072 1082 to 17   tiling clone,   1066/1182
(90 %)
11 diff
(99.1 %id)
BG324590 Kidney, renal cell adenocarcinoma .e 13 to 835 1 to 811   tiling clone,   812/1059
(76 %)
35 diff
(96.7 %id)
BG390639 embryonal carcinoma, cell line, testis .e 28 to 890 1 to 855   tiling clone,   855/897
(95 %)
26 diff
(97.2 %id)
CO247413 Chondrosarcoma Lung Metastasis cell lines, lung .e 33 to 778 1 to 739       739/739
(100 %)
21 diff
(97.2 %id)
AK090661 cerebellum .f 1 to 2902 2 to 2903 T193S tiling clone, available from FLJ,   2903/2903
(100 %)
12 diff
(99.6 %id)
DA056533 cerebellum .f 1 to 537 2 to 538   capped   537/537
(100 %)
0 diff
(100 %id)
DA065083 cerebellum .f 38 to 497 2 to 461   capped   460/460
(100 %)
0 diff
(100 %id)
BQ880593 dorsal root ganglia .f 295 to 1031 1 to 747   tiling clone,   747/867
(86 %)
17 diff
(98.1 %id)
BF737797 bladder_tumor .f 1104 to 1522 1 to 418       418/418
(100 %)
3 diff
(99.3 %id)
CD238666 Pituitary .f 1671 to 2410 1 to 737   tiling clone,   737/740
(99 %)
28 diff
(96.3 %id)
BQ054146 blood, natural killer cells, cell line .f 1998 to 2585 1 to 588   AAA Possibly primed on the genome, locally A rich (23/26 A in genome downstream of last aligned base) 588/588
(100 %)
7 diff
(98.9 %id)
AI889415 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .f 2112 to 2585 474 to 1   tiling clone,   474/474
(100 %)
2 diff
(99.6 %id)
AA379002 synovial membrane .f 2138 to 2469 1 to 332       332/332
(100 %)
1 diff
(99.7 %id)
BF376066 testis_normal .f 2176 to 2329 29 to 180       152/180
(84 %)
6 diff
(96.7 %id)
CA438176 lung, Lung Focal Fibrosis .f 2266 to 2902 655 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 637/637
(100 %)
4 diff
(99.4 %id)
DB296633 cerebellum .f 2353 to 2902 550 to 1       550/550
(100 %)
9 diff
(98.4 %id)
DA821864 pericardium .f 2739 to 3300 2 to 563   tiling clone, capped   562/562
(100 %)
1 diff
(99.9 %id)
BQ082372 Ascites, stomach .f 2943 to 3347 1 to 405   tiling clone,   405/405
(100 %)
2 diff
(99.6 %id)
BI035938 nervous_tumor .f 2969 to 3188 221 to 1       221/221
(100 %)
1 diff
(99.6 %id)
BG707345 brain, hypothalamus .g 1 to 784 1 to 786 P2G A165X tiling clone,   787/786
(100 %)
29 diff
(96.4 %id)
CD249748 embryonic stem cells, WA01, passage 38 .g 444 to 1014 27 to 592   tiling clone,   566/600
(94 %)
12 diff
(98.0 %id)
AA302249 aorta .g 466 to 655 1 to 190       190/195
(97 %)
7 diff
(96.5 %id)
BG009110 placenta_normal .h 1 to 433 434 to 2   tiling clone,   433/434
(99 %)
0 diff
(100 %id)
BG953206 colon .h 281 to 708 434 to 7   tiling clone,   428/435
(98 %)
6 diff
(98.7 %id)
AK096757 Prostate .i-u 1 to 2237 2 to 2234 P72L L73T T74F F75L L76C ... tiling clone, available from FLJ,   2234/2234
(100 %)
10 diff
(99.6 %id)
DA869358 Prostate .i-u 1 to 541 2 to 542   capped   541/541
(100 %)
6 diff
(98.9 %id)
W31419 parathyroid gland, parathyroid tumor .i-u 191 to 635 1 to 448   tiling clone,   448/448
(100 %)
11 diff
(97.6 %id)
DA356145 subthalamic nucleus .i-u 430 to 982 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
AA286947 germinal center B cell .i-u 1604 to 1910 1 to 306   tiling clone,   306/306
(100 %)
3 diff
(99.1 %id)
W04538 parathyroid gland, parathyroid tumor .i-u 2160 to 2236 84 to 8       77/84
(91 %)
0 diff
(100 %id)
BY796645 eye .j 1 to 611 1 to 609 exact tiling clone,   609/609
(100 %)
1 diff
(99.9 %id)
TI_57232729   .k 1 to 541 26 to 567 exact tiling clone, AAA   542/627
(86 %)
16 diff
(97.5 %id)
BI907295 leukocyte .k 8 to 541 1 to 536 exact     536/605
(88 %)
10 diff
(98.4 %id)
AA319126 adrenal gland .k 65 to 286 1 to 222       222/224
(99 %)
1 diff
(99.6 %id)
TI_154195412   .k 66 to 686 1 to 620 S15L A16L L17S L18W D19T ...     620/1040
(59 %)
28 diff
(97.4 %id)
BM724806 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .k 67 to 554 1 to 488 exact fully sequenced, Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 488/488
(100 %)
0 diff
(100 %id)
AJ706123 bone marrow .k 69 to 488 14 to 433 exact     420/433
(96 %)
6 diff
(98.7 %id)
AW905453 nervous_normal .k 81 to 509 1 to 434 D2N L18H D19G N20Q V21C ...     434/434
(100 %)
11 diff
(97.5 %id)
N78384 multiple sclerosis lesions .k 131 to 335 1 to 203   fully sequenced, Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 203/203
(100 %)
3 diff
(98.6 %id)
R57205   .k 133 to 317 1 to 179       180/179
(100 %)
21 diff
(88.3 %id)
TI_154190855   .k 136 to 685 40 to 588   tiling clone, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 549/549
(100 %)
1 diff
(99.9 %id)
CF127307 Chondrosarcoma Lung Metastasis cell lines, lung .k 137 to 685 1 to 548   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 548/548
(100 %)
1 diff
(99.9 %id)
AA328034   .k 139 to 342 1 to 204       204/204
(100 %)
2 diff
(99.1 %id)
AA446495.
matches multiple genes
  .k 144 to 355 1 to 212     also hits gene peynor 212/212
(100 %)
3 diff
(98.6 %id)
AA469898   .k 192 to 591 1 to 398       398/398
(100 %)
4 diff
(99.0 %id)
AA729495 pooled germ cell tumors .k 198 to 682 499 to 15   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 485/490
(98 %)
26 diff
(94.7 %id)
R29357   .k 224 to 342 1 to 117       117/117
(100 %)
2 diff
(98.3 %id)
AA232839 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .k 226 to 525 1 to 300       300/300
(100 %)
1 diff
(99.7 %id)
AA032034 uterus .k 234 to 544 1 to 313       313/313
(100 %)
7 diff
(97.8 %id)
AA974267 pooled germ cell tumors .k 235 to 682 487 to 41   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 447/447
(100 %)
9 diff
(98.0 %id)
N54702 multiple sclerosis lesions .k 237 to 334 1 to 97   fully sequenced, Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 97/97
(100 %)
1 diff
(99.0 %id)
N50044 multiple sclerosis lesions .k 304 to 682 400 to 22   fully sequenced, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 379/379
(100 %)
6 diff
(98.5 %id)
N62613 multiple sclerosis lesions .k 305 to 682 404 to 27   fully sequenced, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 378/378
(100 %)
8 diff
(97.9 %id)
BU741441 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .k 533 to 685 170 to 16   fully sequenced, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 155/155
(100 %)
3 diff
(98.1 %id)
AA031950 uterus .k 548 to 683 137 to 1       137/201
(68 %)
2 diff
(99.1 %id)
AA262353 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .k 553 to 683 131 to 1       131/131
(100 %)
3 diff
(97.8 %id)
BF884027 lung_tumor .l 1 to 256 5 to 276 C2R F3T T4L D5T L6* tiling clone,   272/276
(98 %)
28 diff
(89.9 %id)
BQ331141 lung_tumor .l 14 to 361 21 to 371   tiling clone,   351/378
(92 %)
27 diff
(92.9 %id)
AV701658 adrenal gland Gene AP2A1, variant not shown         Suspected internal deletion, suspected internal deletion, this clone was ignored    
AK124343 uterus Gene AP2A1, variant not shown       available from FLJ, This clone was ignored    
AK302005 testis Gene AP2A1, variant not shown         Suspected internal deletion, this clone was ignored    
BC014214 Muscle, rhabdomyosarcoma Gene AP2A1, variant not shown       available from MGC, AAA This clone was ignored    
DA079052 cerebellum Gene AP2A1, variant not shown       capped Suspected internal deletion, this clone was ignored    
BX487183   Gene AP2A1, variant not shown         This clone was ignored    
EC473358 Prostate Gene AP2A1, variant not shown         This clone was ignored    
BQ640663 eye, retina Gene AP2A1, variant not shown         Suspected internal deletion, this clone was ignored    
AA953882 pooled Gene AP2A1, variant not shown         Suspected internal deletion, this clone was ignored    
AA993745   Gene AP2A1, variant not shown         Suspected internal deletion, this clone was ignored    
BE312112 brain, neuroblastoma Gene AP2A1, variant not shown         This clone was ignored    
BE782187 eye, retinoblastoma Gene AP2A1, variant not shown         This clone was ignored    
BG177912 adenocarcinoma, cell line, Prostate Gene AP2A1, variant not shown         Suspected internal deletion, this clone was ignored    
BQ708951 Spleen Gene AP2A1, variant not shown         Suspected internal deletion, this clone was ignored    
CD580541 brain Gene AP2A1, variant not shown         Suspected internal deletion, suspected internal deletion, this clone was ignored    
TI_1948155291   Gene AP2A1, variant not shown         This clone was ignored    
TI_1948155292   Gene AP2A1, variant not shown         This clone was ignored    
TI_1948155444   Gene AP2A1, variant not shown         This clone was ignored    
TI_1948155445   Gene AP2A1, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i-u, .j, .k, .l Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI